80% of the EVX-01 vaccine targets trigger a tumor-reactive - GlobeNewswire

Retrieved on: 2025-04-28 18:04:13

Tags for this article:

Click the tags to see associated articles and topics

80% of the EVX-01 vaccine targets trigger a tumor-reactive - GlobeNewswire. View article details on hiswai:

Excerpt

... immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting. April 28, 2025 08:00 ET | Source: Evaxion Biotech Follow

Article found on: www.globenewswire.com